Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 6
Submit an article Journal homepage
226
Views
6
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Outcome and prognostic factors among patients who underwent a second transplantation for disease relapse post the first allogeneic cell transplantation

Takayoshi TachibanaDepartment of Hematology and Clinical Immunology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan; ;Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan; Correspondence[email protected]
,
Kenji MatsumotoYokohama City University Medical Center, Yokohama, Japan;
,
Masatsugu TanakaDepartment of Hematology, Kanagawa Cancer Center, Yokohama, Japan;
,
Maki HagiharaYokohama City University Medical Center, Yokohama, Japan;
,
Kenji MotohashiYokohama City University Medical Center, Yokohama, Japan;
,
Wataru YamamotoYokohama City University Medical Center, Yokohama, Japan;
,
Eriko OgusaDepartment of Hematology, Kanagawa Cancer Center, Yokohama, Japan;
,
Satoshi KoyamaDepartment of Hematology and Clinical Immunology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan;
,
Ayumi NumataYokohama City University Medical Center, Yokohama, Japan;
,
Naoto TomitaDepartment of Hematology and Clinical Immunology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan;
,
Jun TaguchiDepartment of Hematology, Shizuoka Red Cross Hospital, Shizuoka, Japan
,
Shin FujisawaYokohama City University Medical Center, Yokohama, Japan;
,
Heiwa KanamoriDepartment of Hematology, Kanagawa Cancer Center, Yokohama, Japan;
&
Hideaki NakajimaDepartment of Hematology and Clinical Immunology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan;
show all
Pages 1403-1411 | Received 17 Jun 2016, Accepted 25 Sep 2016, Published online: 14 Oct 2016

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Sebastian Mayer & Koen van Besien. (2017) Second allogeneic transplantation: ever? never? or sometimes . Leukemia & Lymphoma 58:6, pages 1279-1280.
Read now

Articles from other publishers (5)

Naonori Harada, Hiroshi Okamura, Yosuke Makuuchi, Masatomo Kuno, Teruhito Takakuwa, Mika Nakamae, Mitsutaka Nishimoto, Yasuhiro Nakashima, Hideo Koh, Masayuki Hino & Hirohisa Nakamae. (2023) Third HLA-haploidentical stem cell transplantation using post-transplant cyclophosphamide for relapsed acute leukemia. Bone Marrow Transplantation 58:12, pages 1403-1405.
Crossref
Mohamed A. Kharfan-Dabaja, Tea Reljic, Farah Yassine, Taiga Nishihori, Arni Kumar, Mitchell M. Tawk, Katelyn Keller, Ernesto Ayala, Bipin Savani, Mohamad Mohty, Mahmoud Aljurf & Wael Saber. (2022) Efficacy of a Second Allogeneic Hematopoietic Cell Transplant in Relapsed Acute Myeloid Leukemia: Results of a Systematic Review and Meta-Analysis. Transplantation and Cellular Therapy 28:11, pages 767.e1-767.e11.
Crossref
Takayoshi Tachibana, Masatsugu Tanaka, Maki Hagihara, Katsumichi Fujimaki, Heiwa Kanamori & Hideaki Nakajima. (2022) Outcomes in patients with acute lymphoblastic leukemia who underwent second allogeneic hematopoietic cell transplantation for relapse after first transplantation. International Journal of Hematology 116:4, pages 594-602.
Crossref
Akihiko Izumi, Takayoshi Tachibana, Taiki Ando, Masatsugu Tanaka, Heiwa Kanamori & Hideaki Nakajima. (2021) A case series of patients treated with inotuzumab ozogamicin for acute lymphoblastic leukemia relapsed after allogeneic hematopoietic cell transplantation. International Journal of Hematology 115:1, pages 69-76.
Crossref
José Carlos Jaime‐Pérez, Ernesto Picón‐Galindo, José Luis Herrera‐Garza & David Gómez‐Almaguer. (2020) Outcomes of second hematopoietic stem cell transplantation using reduced‐intensity conditioning in an outpatient setting. Hematological Oncology 39:1, pages 87-96.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.